An Open-Label, Balanced, Randomized, Single-Dose, Four Treatment, Four Period, Four Sequence, Four Way Crossover Study of Oral Bioavailability of Sundalp/Micellon Standardized To Min. 2.25% Curcuminoids Capsules 500 mg1 Soft gel Capsule of Manufactured By Sferalp SAVia Cantonale 77, CH-6998 Monteggio, Switzerland T1, Sundalp/ Micellon Standardized To Min. 2.25% Curcuminoids Capsules 2000 Mg 4*500 mg Soft gel Capsules of Manufactured By Sferalp SA Via Cantonale 77, CH-6998 Monteggio, Switzerland T2 with Curcumin Phytosome 500 Mg Turmeric Rhizome Extract Curcuma Longa Phosphatidyl Choline Complex Meriva Turmeric PhytosomeStandardized To Min. 18% Curcuminoids 90 Mg 1 Capsule Manufactured By Now Foods 395 S. Glen Ellyn Rd., Bloomingdale, IL 60108, USA R1, Jigsaw Health Curcumin C 3 Complex 500 Mg NLT 95% Total Curcuminoids Curcuma Longa Rhizomes 1 Capsule Manufactured By Jigsaw Health LLC 9035 E Pima Center Pkwy Suite 4 Scottsdale AZ 85258 USA R2 - In Healthy, Adult, Human Subjects Under Fasting Conditions

Pharmabase SA0 个研究点目标入组 24 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Normal healthy human adult subjects of age 18-45 years with BMI between 18.5 kg/m2 to 29.99 kg/m2
•Subjects whose screening laboratory values are within normal limits or considered by the physician or principal/clinical investigator to be of no clinical significance
•Healthy as documented by the medical history, physical examination (including but may not be limited to an evaluation of the cardiovascular, gastrointestinal, respiratory, musculoskeletal and central nervous systems) and vital sign assessments.
•Generally healthy as documented by 12-lead electrocardiogram (ECG), X-Ray and clinical laboratory assessments.
•Willing to consume ova lacto vegeterian diet

•Evidence of allergy or known hypersenstivity to curcumin or its inactive ingredients.
•Renal or liver impairment.
•Any disease or condition which might compromise the haemopoeitic, gastrointestinal, renal, hepatic, cardiovascular, Musculoskeletal, respiratory, central nervous system, diabetes, psychosis or any other body system.
•History of alcohol addiction or abuse.
•Consumption of caffeine and /or Xanthine containing products (i.e. coffee, tea, chocolate, and caffeine-containing sodas, colas, etc.) tobacco containing products for at least 48.00 hours prior to check-inand throughout the entire study.
•Consumption of alcohol and its products, grapefruit and/ or its juice and poppy containing foods within 72.00 hours prior to check-inand throughout the entire study.
•History difficulty in swallowing, accessibility of veins.

发起方

Pharmabase SA